Back to top

earnings-estimates-revisions: Archive

Zacks Equity Research

Compared to Estimates, Tyson (TSN) Q3 Earnings: A Look at Key Metrics

The headline numbers for Tyson (TSN) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

TSNPositive Net Change

Zacks Equity Research

Idexx (IDXX) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

Although the revenue and EPS for Idexx (IDXX) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

IDXXNegative Net Change

Zacks Equity Research

Compared to Estimates, Northern Oil and Gas (NOG) Q2 Earnings: A Look at Key Metrics

The headline numbers for Northern Oil and Gas (NOG) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

NOGNegative Net Change

Zacks Equity Research

Bruker (BRKR) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for Bruker (BRKR) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

BRKRPositive Net Change

Zacks Equity Research

Is It Worth Investing in Celsius (CELH) Based on Wall Street's Bullish Views?

According to the average brokerage recommendation (ABR), one should invest in Celsius (CELH). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

CELHNegative Net Change

Zacks Equity Research

Viking Therapeutics (VKTX) Is Considered a Good Investment by Brokers: Is That True?

The average brokerage recommendation (ABR) for Viking Therapeutics (VKTX) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

VKTXNegative Net Change

Zacks Equity Research

ON Semiconductor Corp. (ON) Reports Q2 Earnings: What Key Metrics Have to Say

The headline numbers for ON Semiconductor Corp. (ON) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

ONNegative Net Change

Zacks Equity Research

Compared to Estimates, CommScope (COMM) Q2 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for CommScope (COMM) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

COMMNegative Net Change

Zacks Equity Research

Compared to Estimates, W.W. Grainger (GWW) Q2 Earnings: A Look at Key Metrics

Although the revenue and EPS for W.W. Grainger (GWW) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

GWWPositive Net Change

Zacks Equity Research

Mettler-Toledo (MTD) Reports Q2 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Mettler-Toledo (MTD) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

MTDPositive Net Change

Zacks Equity Research

Here's What Key Metrics Tell Us About Moderna (MRNA) Q2 Earnings

Although the revenue and EPS for Moderna (MRNA) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

MRNANegative Net Change

Urmimala Biswas

Tempus AI Stock Before Q2 Earnings Release: To Buy or Not to Buy?

TEM surged 34.5% in Q2 on AI-driven deals and product momentum, but valuation and profit concerns linger ahead of earnings.

AZNPositive Net Change TXGNegative Net Change SOPHNegative Net Change TEMNegative Net Change

Zacks Equity Research

Compared to Estimates, Dominion Energy (D) Q2 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for Dominion Energy (D) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

DPositive Net Change

Zacks Equity Research

Stryker (SYK) Reports Q2 Earnings: What Key Metrics Have to Say

The headline numbers for Stryker (SYK) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

SYKPositive Net Change

Zacks Equity Research

Here's What Key Metrics Tell Us About ICF (ICFI) Q2 Earnings

The headline numbers for ICF (ICFI) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

ICFIPositive Net Change

Zacks Equity Research

Surging Earnings Estimates Signal Upside for Materion (MTRN) Stock

Materion (MTRN) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

MTRNNegative Net Change

Zacks Equity Research

Earnings Estimates Moving Higher for Newmark Group (NMRK): Time to Buy?

Newmark Group (NMRK) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

NMRKPositive Net Change

Zacks Equity Research

Why Kiniksa Pharmaceuticals International, plc (KNSA) Might be Well Poised for a Surge

Kiniksa Pharmaceuticals International, plc (KNSA) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

KNSANegative Net Change

Zacks Equity Research

Hudson Tech (HDSN) Upgraded to Strong Buy: What Does It Mean for the Stock?

Hudson Tech (HDSN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

HDSNNegative Net Change

Zacks Equity Research

All You Need to Know About Spok (SPOK) Rating Upgrade to Buy

Spok (SPOK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

SPOKNegative Net Change

Zacks Equity Research

All You Need to Know About TowneBank (TOWN) Rating Upgrade to Buy

TowneBank (TOWN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

TOWNNegative Net Change

Zacks Equity Research

Meta Platforms (META) Upgraded to Strong Buy: Here's What You Should Know

Meta Platforms (META) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

METANegative Net Change

Zacks Equity Research

What Makes LATAM (LTM) a New Strong Buy Stock

LATAM (LTM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

LTMPositive Net Change

Zacks Equity Research

Colony Credit (BRSP) Upgraded to Buy: What Does It Mean for the Stock?

Colony Credit (BRSP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

BRSPPositive Net Change

Zacks Equity Research

All You Need to Know About Apollo Commerical Finance (ARI) Rating Upgrade to Strong Buy

Apollo Commerical Finance (ARI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

ARIPositive Net Change